Details for New Drug Application (NDA): 213762
✉ Email this page to a colleague
The generic ingredient in ARFORMOTEROL TARTRATE is arformoterol tartrate. There are four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the arformoterol tartrate profile page.
Summary for 213762
Tradename: | ARFORMOTEROL TARTRATE |
Applicant: | Be Pharms |
Ingredient: | arformoterol tartrate |
Patents: | 0 |
Pharmacology for NDA: 213762
Mechanism of Action | Adrenergic beta2-Agonists |
Suppliers and Packaging for NDA: 213762
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ARFORMOTEROL TARTRATE | arformoterol tartrate | SOLUTION;INHALATION | 213762 | ANDA | Slate Run Pharmaceuticals | 70436-151 | 70436-151-57 | 30 POUCH in 1 CARTON (70436-151-57) / 1 VIAL in 1 POUCH (70436-151-19) / 2 mL in 1 VIAL |
ARFORMOTEROL TARTRATE | arformoterol tartrate | SOLUTION;INHALATION | 213762 | ANDA | Slate Run Pharmaceuticals | 70436-151 | 70436-151-58 | 15 POUCH in 1 CARTON (70436-151-58) / 4 VIAL in 1 POUCH (70436-151-20) / 2 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INHALATION | Strength | EQ 0.015MG BASE/2ML | ||||
Approval Date: | Jun 22, 2021 | TE: | AN | RLD: | No |
Complete Access Available with Subscription